The Canton of Vaud is expanding colorectal cancer screening to include a larger portion of its population. The initiative now encompasses men and women aged 70 to 74, whereas previously screening was limited to those between 50 and 69. This expansion aims to improve early detection rates for a cancer that remains a significant public health concern.
Approximately 4,600 modern cases of colorectal cancer are diagnosed annually in Switzerland, with around 400 of those occurring in the Canton of Vaud. According to Unisanté, nearly half of these diagnoses are made after the age of 70, highlighting the importance of extending screening access to this age group.
“This will offer those aged 70–74 equitable access to this essential preventative measure,” said Dr. Romain Freund, head of the Vaud Cancer Screening Programs at Unisanté. The expansion underscores the commitment to ensuring all residents have opportunities for early detection and improved health outcomes.
Covered Under Basic Insurance
Colorectal cancer screening can prevent the disease by removing precancerous lesions, known as polyps, Unisanté explains. The Lausanne-based university center notes that, in the majority of cases, cancer is detected at an early stage when screening is utilized, leading to a greater than 90% chance of successful treatment.
Individuals eligible for screening can choose between two options: a fecal immunochemical test (FIT) for blood in the stool every two years, or a colonoscopy every ten years. Both tests are covered at 90% by basic health insurance, regardless of the chosen deductible, meaning participants are responsible for only 10% of the cost, Unisanté clarified.
